CAD 7.15
(1.85%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | 1.12 Billion USD | -8.92% |
2022 | 1.23 Billion USD | 32.12% |
2021 | 938.38 Million USD | 79.93% |
2020 | 521.53 Million USD | 106.29% |
2019 | 252.81 Million USD | 145.89% |
2018 | 102.81 Million CAD | 419.84% |
2017 | 19.77 Million CAD | 12173.63% |
2016 | 161.14 Thousand CAD | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q2 | 303.44 Million USD | 1.96% |
2024 Q1 | 297.61 Million USD | 3.71% |
2023 Q3 | 275.21 Million USD | -2.34% |
2023 Q4 | 286.97 Million USD | 4.27% |
2023 Q1 | 289.1 Million USD | -4.33% |
2023 Q2 | 281.8 Million USD | -2.53% |
2023 FY | 1.12 Billion USD | -8.92% |
2022 Q2 | 320.28 Million USD | 0.61% |
2022 Q4 | 302.2 Million USD | 0.47% |
2022 FY | 1.23 Billion USD | 32.12% |
2022 Q1 | 318.34 Million USD | 4.26% |
2022 Q3 | 300.79 Million USD | -6.09% |
2021 Q4 | 305.34 Million USD | 36.26% |
2021 Q3 | 224.09 Million USD | 4.17% |
2021 Q2 | 215.12 Million USD | 10.99% |
2021 Q1 | 193.82 Million USD | 15.07% |
2021 FY | 938.38 Million USD | 79.93% |
2020 Q1 | 96.05 Million USD | 20.53% |
2020 Q4 | 168.43 Million USD | 23.6% |
2020 Q3 | 136.27 Million USD | 12.84% |
2020 FY | 521.53 Million USD | 106.29% |
2020 Q2 | 120.76 Million USD | 25.72% |
2019 Q4 | 79.69 Million USD | 12.67% |
2019 Q1 | 44.47 Million USD | 23.73% |
2019 FY | 252.81 Million USD | 145.89% |
2019 Q2 | 57.92 Million USD | 30.23% |
2019 Q3 | 70.73 Million USD | 22.12% |
2018 Q1 | 15.24 Million USD | 15.15% |
2018 Q3 | 28.32 Million USD | 21.58% |
2018 FY | 102.81 Million CAD | 419.84% |
2018 Q4 | 35.94 Million USD | 26.9% |
2018 Q2 | 23.29 Million USD | 52.81% |
2017 FY | 19.77 Million CAD | 12173.63% |
2017 Q2 | 2.22 Million USD | 40.77% |
2017 Q4 | 13.24 Million USD | 292.35% |
2017 Q3 | 3.37 Million USD | 51.6% |
2017 Q1 | 1.58 Million USD | 0.0% |
2016 Q4 | - USD | 0.0% |
2016 Q3 | - USD | 0.0% |
2016 FY | 161.14 Thousand CAD | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
Aion Therapeutic Inc. | 367.47 Thousand CAD | -307180.96% |
Ayurcann Holdings Corp. | 25.15 Million CAD | -4388.476% |
Blueberries Medical Corp. | 288.27 Thousand CAD | -391610.954% |
The BC Bud Corporation | 61.48 Thousand CAD | -1836523.727% |
BioNxt Solutions Inc. | 372.24 Thousand CAD | -303245.091% |
CordovaCann Corp. | 13.59 Million CAD | -8206.123% |
Christina Lake Cannabis Corp. | 11.77 Million CAD | -9485.933% |
Captor Capital Corp. | 36.76 Million CAD | -2971.297% |
City View Green Holdings Inc. | 8582.00 CAD | -13157590.515% |
1CM Inc. | 35.34 Million CAD | -3095.096% |
Global Hemp Group Inc. | - CAD | -Infinity% |
Greenway Greenhouse Cannabis Corporation | 5.23 Million CAD | -21489.887% |
IM Cannabis Corp. | 48.8 Million CAD | -2213.73% |
Lobe Sciences Ltd. | 840.53 Thousand CAD | -134242.335% |
Maple Leaf Green World Inc. | - CAD | -Infinity% |
Mountain Valley MD Holdings Inc. | 60 Thousand CAD | -1881888.333% |
Nextleaf Solutions Ltd. | 8.17 Million CAD | -13704.967% |
Ovation Science Inc. | 61.93 Thousand CAD | -1823119.879% |
Pharmadrug Inc. | - CAD | -Infinity% |
Captiva Verde Wellness Corp. | 174.78 Thousand CAD | -645939.465% |
RAMM Pharma Corp. | 5.06 Million CAD | -22192.884% |
RIV Capital Inc. | 7.48 Million CAD | -14979.908% |
Revive Therapeutics Ltd. | - CAD | -Infinity% |
Red White & Bloom Brands Inc. | 88.33 Million CAD | -1178.333% |
SLANG Worldwide Inc. | 35.68 Million CAD | -3064.583% |
1933 Industries Inc. | 18.27 Million CAD | -6079.476% |
Red Light Holland Corp. | 4.75 Million CAD | -23662.574% |
Top Strike Resources Corp. | 13.32 Million CAD | -8372.762% |
Xebra Brands Ltd. | 106.85 Thousand CAD | -1056652.609% |
Adastra Holdings Ltd. | 22.22 Million CAD | -4981.272% |